Lupin launches pregnancy prevention tablets in the US
Pharma major Lupin today said it has launched Mibelas 24 Fe, used for pregnancy prevention, in the US market.
Pharma major Lupin today said it has launched Mibelas 24 Fe, used for pregnancy prevention, in the US market.
"The company today announced the launch of Mibelas 24 Fe (Norethindrone Acetate and Ethinyl Estradiol chewable tablets, 1 mg/0.02 mg and Ferrous Fumarate tablets, 75 mg) having received an approval from the USFDA earlier," Lupin said in a BSE filing.
The tablet is the AB rated generic equivalent of Allergan Pharmaceuticals International Minastrin 24 Fe tablets, it added.
According to IMS MAT December 2016 data, Minastrin 24 Fe chewable tablets had the US sales of USD 360.5 million.
Shares of Lupin closed 0.41 per cent up at Rs 1,456.40 on BSE.
(This article has not been edited by DNA's editorial team and is auto-generated from an agency feed.)